164 related articles for article (PubMed ID: 20463325)
1. The monocyte chemokine receptor CX3CR1 does not play a significant role in the pathogenesis of experimental autoimmune uveoretinitis.
Kezic J; McMenamin PG
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5121-7. PubMed ID: 20463325
[TBL] [Abstract][Full Text] [Related]
2. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
Jiang HR; Lumsden L; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
[TBL] [Abstract][Full Text] [Related]
3. The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation.
Copland DA; Wertheim MS; Armitage WJ; Nicholson LB; Raveney BJ; Dick AD
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5458-65. PubMed ID: 18757507
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
[TBL] [Abstract][Full Text] [Related]
6. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
[TBL] [Abstract][Full Text] [Related]
7. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
8. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
Butler TL; McMenamin PG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin is proinflammatory in experimental autoimmune uveitis.
Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
[TBL] [Abstract][Full Text] [Related]
10. In vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.
Chen X; Kezic JM; Forrester JV; Goldberg GL; Wicks IP; Bernard CC; McMenamin PG
J Neuroinflammation; 2015 Jan; 12():17. PubMed ID: 25623142
[TBL] [Abstract][Full Text] [Related]
11. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
Zhao J; Chen M; Xu H
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
[TBL] [Abstract][Full Text] [Related]
12. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
13. Retinal microglia and uveal tract dendritic cells and macrophages are not CX3CR1 dependent in their recruitment and distribution in the young mouse eye.
Kezic J; Xu H; Chinnery HR; Murphy CC; McMenamin PG
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1599-608. PubMed ID: 18385080
[TBL] [Abstract][Full Text] [Related]
14. Differential turnover rates of monocyte-derived cells in varied ocular tissue microenvironments.
Kezic J; McMenamin PG
J Leukoc Biol; 2008 Sep; 84(3):721-9. PubMed ID: 18577714
[TBL] [Abstract][Full Text] [Related]
15. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice.
Sonoda KH; Yoshimura T; Egashira K; Charo IF; Ishibashi T
Acta Ophthalmol; 2011 Mar; 89(2):e180-8. PubMed ID: 20584001
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
Kawashima H; Fujiño Y; Mochizuki M
Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
[TBL] [Abstract][Full Text] [Related]
18. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2.
Dagkalis A; Wallace C; Xu H; Liebau S; Manivannan A; Stone MA; Mack M; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4288-94. PubMed ID: 19357362
[TBL] [Abstract][Full Text] [Related]
19. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
[TBL] [Abstract][Full Text] [Related]
20. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
